Retractable Technologies Inc (RVP)
0.671
-0.02
(-2.89%)
USD |
NYAM |
Nov 14, 12:31
Retractable Technologies Research and Development Expense (Quarterly): 0.1991M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.1991M |
| March 31, 2024 | 0.1423M |
| December 31, 2023 | 0.1617M |
| September 30, 2023 | 0.151M |
| June 30, 2023 | 0.1388M |
| March 31, 2023 | 0.1298M |
| December 31, 2022 | 0.1181M |
| September 30, 2022 | 0.1057M |
| June 30, 2022 | 0.2064M |
| March 31, 2022 | 0.0955M |
| December 31, 2021 | 0.1539M |
| September 30, 2021 | 0.1992M |
| June 30, 2021 | 0.399M |
| March 31, 2021 | 0.1493M |
| December 31, 2020 | 0.1752M |
| September 30, 2020 | 0.1346M |
| June 30, 2020 | 0.1263M |
| March 31, 2020 | 0.1385M |
| December 31, 2019 | 0.1382M |
| September 30, 2019 | 0.1349M |
| June 30, 2019 | 0.1155M |
| March 31, 2019 | 0.1275M |
| December 31, 2018 | 0.1892M |
| September 30, 2018 | 0.1465M |
| June 30, 2018 | 0.1415M |
| Date | Value |
|---|---|
| March 31, 2018 | 0.1442M |
| December 31, 2017 | 0.2748M |
| September 30, 2017 | 0.1599M |
| June 30, 2017 | 0.1574M |
| March 31, 2017 | 0.1484M |
| December 31, 2016 | 0.1821M |
| September 30, 2016 | 0.1179M |
| June 30, 2016 | 0.1469M |
| March 31, 2016 | 0.1249M |
| December 31, 2015 | 0.1978M |
| September 30, 2015 | 0.1258M |
| June 30, 2015 | 0.1677M |
| March 31, 2015 | 0.1163M |
| December 31, 2014 | 0.1106M |
| September 30, 2014 | 0.1292M |
| June 30, 2014 | 0.1922M |
| March 31, 2014 | 0.1847M |
| December 31, 2013 | 0.1888M |
| September 30, 2013 | 0.268M |
| June 30, 2013 | 0.1994M |
| March 31, 2013 | 0.1808M |
| December 31, 2012 | 0.2708M |
| September 30, 2012 | 0.244M |
| June 30, 2012 | 0.1655M |
| March 31, 2012 | 0.1915M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.0955M
Minimum
Mar 2022
0.399M
Maximum
Jun 2021
0.1612M
Average
0.1423M
Median
Mar 2024
Research and Development Expense (Quarterly) Benchmarks
| Plus Therapeutics Inc | 2.773M |
| Perspective Therapeutics Inc | 9.275M |
| InfuSystems Holdings Inc | -- |
| Xtant Medical Holdings Inc | 0.636M |
| Catheter Precision Inc | 0.081M |